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Received May 8, 2012; accepted July 3, 2012AbstractBackground: Adhesive capsulitis is commonly associated with medical diseases such as diabetes mellitus, hyperthyroidism, and obesity. Intra-
articular injection has been used to speed recovery and relieve pain associated with frozen shoulder. In this study, we evaluated and compared the
effects of an intra-articular injection of corticosteroid and lidocaine in the treatment of primary adhesive capsulitis in overweight and normal-
weight patients.
Methods: This is a prospective clinical study of patients with adhesive capsulitis, in which the main treatment strategy was an intra-articular
injection of corticosteroid (3 mL) and lidocaine (3 mL). Active range of motion exercise was initiated immediately after the injection and
performed four times daily. The evaluation included the recording of a detailed medical and orthopedic history, and the assessment of pain and
function by determining the Constant score at baseline (before injection) and every 2 weeks thereafter. Patients were classified as normal weight
(body mass index [BMI] < 25 kg/m2) or overweight (BMI  25 kg/m2). The Constant scores of all patients were compared at 8 weeks after
injection.
Results: After clinical examinations and radiographic and ultrasonographic studies, 79 patients were treated for adhesive capsulitis between 2010
and 2012. In the normal-weight group, the mean Constant score increased from 35.4 to 74.6 after 8 weeks, whereas in the overweight group, the
mean Constant score increased from 32.0 to 47.2. There was a significant difference in the mean Constant score between the normal-weight and
overweight groups at 8 weeks.
Conclusion: Active range of motion exercise after an intra-articular injection of corticosteroid and lidocaine improved pain and functional
outcome at 8 weeks in normal-weight (BMI < 25 kg/m2) patients with primary adhesive capsulitis. Manipulation under anesthesia may be
considered a priority in overweight patients.
Copyright  2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Adhesive capsulitis (frozen shoulder) is characterized by
a gradual increase in stiffness and pain in the shoulder. It is
said to be self-limiting over a period of 1e2 years, during
which time it can cause considerable disability. Many* Corresponding author. Dr. Tung-Fu Huang, Department of Orthopedics
and Traumatology, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai
Road, Taipei 112, Taiwan, ROC.
E-mail addresses: smtfhuang@gmail.com, huangtf@vghtpe.gov.tw (T.-F.
Huang).
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http://dx.doi.org/10.1016/j.jcma.2012.12.008treatment regimens, including conservative treatment, manip-
ulation under anesthesia, and intra-articular injection, have
been used to accelerate recovery and relieve pain associated
with frozen shoulder.1,2 Excellent results following distension
of the shoulder joint, which can be performed with or without
arthrography or steroid injection, have been reported.3,4
Adhesive capsulitis is commonly associated with diabetes
mellitus, hyperthyroidism, hypothyroidism, cardiac disease,
and pulmonary disease.5 Obesity is commonly defined in
terms of body mass index (BMI) and is related to the over-
production of inflammatory cytokines. Currently, there is nohinese Medical Association. All rights reserved.
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obesity and adhesive capsulitis.
We present a prospective study of a series of patients with
frozen shoulders treated using a protocol consisting of self-
assisted active range of motion exercise after receiving a sin-
gle injection of corticosteroid and a local anesthetic in the
frozen phase. The purpose of this study was to examine the
effects of this protocol on the functional results of primary
frozen shoulder, and to compare the outcomes in overweight
and normal-weight patients.Table 1
Demographic data.
Normal weight Overweight p
Number 47 32 d
Mean BMI 23.4 29.3 0.04
Mean age 48.6 56.0 0.74
Gender (% male) 34.0 18.8 0.37
Diabetes mellitus (%) 34.0 40.6 0.72
Duration of symptoms (mo) 4.5 3.6 0.842. Methods
Between 2010 and 2012, 79 patients with primary adhesive
capsulitis in only one shoulder were enrolled in this study after
institutional review board approval. Patients with rotator cuff
tear or rheumatic disease, and those who had received a steroid
injection or undergone previous shoulder surgery in the
affected shoulder were excluded.
All patients received a 3-mL intra-articular injection of
corticosteroid (Shincort, 10 mg/mL) mixed with 3 mL of 2%
lidocaine (Xylocaine 2%, 20 mg/mL) in the 1st. The mixture
was injected into the glenohumeral joint by an experienced
orthopedic surgeon. Patients were seated in a chair, and the
affected shoulder was bent and adducted. After intra-articular
injection at the outpatient department of our institution, these
patients participated in a self-assisted exercise program
consisting of gentle active-assisted forward flexion, abduc-
tion, external rotation, and adduction. The exercises were
repeated 15e20 times slowly within 15 minutes at a fre-
quency of four times per day. Additionally, patients were
instructed to stretch the shoulder gently against the limits of
tolerance, and to avoid strengthening exercises until shoulder
pain subsided. We did not specifically prescribe, discourage,
or prohibit the use of oral nonsteroidal anti-inflammatory
medications. More aggressive treatment (manipulation or
capsular release) was not recommended until it was deter-
mined that the protocol had failed (the patient was dissatisfied
with the outcome) after performing the exercise program for
at least 3 months.
Initial evaluation included the recording of a detailed
medical history, including the history of the shoulder problem.
Subjective patient function and pain were evaluated by
determining the Constant score at each follow-up visit.
Additional follow-up included patient assessments at 2, 4, and
8 weeks, and 6 months at the outpatient department. The need
for continuing compliance with the exercise protocol was
strongly reiterated and recommended at each visit.
Demographic data, including age, sex, and presence of
diabetes mellitus, were also obtained. BMI was calculated for
each patient using the weight in kilograms divided by height in
meters squared. For the purposes of statistical analysis, pa-
tients were classified as normal weight (BMI < 25 kg/m2) or
overweight (BMI  25 kg/m2). Mean differences between
baseline and 8-week scores were compared between the
overweight and normal-weight patients. Statistical analysiswas performed using paired Student’s t test. The p
values < 0.05 were considered statistically significant.
3. Results
Seventy-nine patients completed an after-treatment follow-
up of 8 weeks, including physical examination and outcome
assessment. Forty-seven patients were classified into the nor-
mal weight group, and 32 were deemed overweight. There
were 22 (28%) men and 57 (72%) women, with a mean age of
52.3 years (range 42e63 years). There was no significant
difference between the ages of the male and female patients
between the two groups. The mean duration of shoulder pain
was 4.1 months (range 3e6 months).
Baseline demographic data of the two groups were similar
with regard to age, sex, presence of diabetes mellitus, and
duration of symptoms (Table 1). There was one patient with
a thyroid goiter who had normal thyroid function. The per-
centage of patients with diabetes mellitus was slightly higher
in the overweight group than the normal-weight group, but the
difference was not significant.
At 8 weeks, there were 55 (69.6%) patients with excellent
results, and 16 (7.5%) patients with good results according to
the Constant score. Of the patients with 55 excellent results,
there were 42 (76.3%) women and 13 (23.7%) men. Eight
patients reported poor functional outcome based on the Con-
stant score. These eight patients were deemed as treatment
failures, and included five women and three men. Three pa-
tients with no improvement after 3 months of treatment were
also reported to have poor outcomes. All three patients,
including one patient with diabetes mellitus, underwent suc-
cessful manipulation under anesthesia.
At 8 weeks, the mean Constant score increased from 35.4 to
74.6 in the normal-weight group, and from 32.0 to 47.6 in the
overweight group. It was noted that there was a significant
difference between the Constant score in the normal weight
and overweight groups (Table 2). In the eight poor outcomes at
8 weeks, the demographic variables were analyzed for any
association with subjective dissatisfaction, and the eventual
need for manipulation under anesthesia. Treatment failure and
the need for manipulation were not associated with age, sex,
duration of symptoms, or the presence of diabetes mellitus. In
the eight failed patients, the mean BMI was 27.8 kg/m2 (range,
24.0e32.3 kg/m2). Satisfaction with the outcomes then was
determined by questioning the patients. Four of the eight pa-
tients (50%) were satisfied with the improvement in pain, and
one was considered to be unchanged.
Table 2
Baseline and 8-week outcomes.
Constant score Normal weight Overweight p
Mean baseline 35.4 32.0 0.89
Mean at 8 wk 74.6 47.2 0.04
Mean change in score 36.2 15.2 0.04
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In this study, we prospectively evaluated the functional
outcomes of patients with primary adhesive capsulitis who
were treated with active range of motion exercise after a single
intra-articular injection of steroid and lidocaine. The vast
majority of patients were treated successfully, with an excel-
lent Constant score at 8 weeks postinjection. This prospective
study provided data that enabled us to analyze the reduction in
patient pain and improvement in function, and also observe the
relationship, if any, between the effectiveness of treatment and
patient factors.
Steroid injection in the glenohumeral joint is one of the
most well known treatments for frozen shoulder. Moreover,
there are numerous reports in the literature that a single in-
jection can be effective to address this problem.6 When
compared with an ultrasound-guided injection procedure, the
improvement in pain intensity, range of motion, and shoulder
function score with the use of a blind technique was sig-
nificantly reduced by the second week. However, no further
significant differences in improvement were observed beyond
the 3rd week.7 Subacromial injection is an alternative mo-
dality; however, injection at the glenohumeral joint typically
leads to earlier pain relief.8
Oral or intra-articular corticosteroid treatment may be of
limited, short-term benefit in adhesive capsulitis.2,9,10 The
distension effect may result in a longer and gradual relief of
pain, which is attained despite unchanged rigidity.11 To date,
there is no consensus regarding the necessity of capsular
rupture or volume that is sufficient for this distension effect.12
Furthermore, in one study, there was no significant difference
in outcome between the high-(triamcinolone acetonide,
40 mg) and low-dose (20 mg) corticosteroid groups, indicating
the preferred use of a lower dose at the initial stage.13 Com-
bined with range of motion exercise, it is effective and faster
in improving shoulder pain and disability in primary adhesive
capsulitis.14 It is important to continue arthrographic capsular
distension in order to achieve maximum improvement in range
of motion. In our study, patients were instructed to actively
stretch against the limits before any assistance. There are ad-
vantages to both active and passive range of motion, as
demonstrated by the fact that both conventional physiotherapy
and continuous passive range of motion brought statistically
significant improvement in pain and function.15
In this prospective study, we found that the treatment pro-
tocol resulted in significant improvement in the Constant score
in most patients, regardless of age, sex, or presence of diabetes
mellitus. There may be a different mechanism in diabetic
patients, and poorer response over the long term was noted.4,16
However, we assume that steroid and lidocaine provide ananti-inflammatory and analgesic effect with distention of the
contracted capsule. Active range of motion exercise further
helps maintain the improved range of motion, shortens the
natural course of the disease process, and improves function at
8 weeks in normal-weight patients. The regimen is also rela-
tively easy for patients to perform when provided with clear
instruction.
There is a trend toward comparatively worse results in men,
but not in patients with coronary artery disease or hypothy-
roidism.17 There is no previous study examining the effect of
obesity on the treatment of primary adhesive capsulitis. Our
data suggest that being overweight (BMI  25 kg/m2) resulted
in a significantly lower improvement in the Constant score,
when treated with active range of motion exercise after intra-
articular injection. One potential explanation for this finding is
the more severe inflammation in obese patients, which is also
the possible pathophysiology in obese patients with psoria-
sis18: the higher the soft tissue pressure, the higher the dosage
and volume necessary to achieve capsular extension, and the
poorer the compliance with rehabilitation exercise.
For those without range of motion improvement during our
study, questionnaire responses still indicated that most of the
patients were satisfied with the extent of their pain improve-
ment. Further studies with appropriate controls are needed to
confirm the exact mechanism influencing the outcome in
overweight patients.
On the basis of the findings of our study, we recommend
that normal-weight patients with primary adhesive capsulitis
should be treated with active range of motion exercise after
intra-articular injection of corticosteroid and lidocaine. The
active range of motion exercise should be continued for at
least 8 weeks before more aggressive or invasive management
is considered. Our experience indicated that a significant
improvement in the Constant score should be expected at 8
weeks.
This study has some limitations. First, the procedure was
led by a single senior surgeon whose results may not be
applicable to the wider orthopedic community. Second, there
was only one method of management, which was assessed
without randomization or blinding. Finally, the active range of
motion exercise regimen may differ in patients, even provided
with clear instructions.
In conclusion, active range of motion exercise after a single
intra-articular injection of corticosteroid and lidocaine
improved pain and functional outcome at 8 weeks in normal-
weight (BMI < 25 kg/m2) patients with primary adhesive
capsulitis. Manipulation under anesthesia or other aggressive
treatment may be considered a priority in overweight patients.
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